+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Adaptation to the deleterious effects of antimicrobial drug resistance mutations by compensatory evolution



Adaptation to the deleterious effects of antimicrobial drug resistance mutations by compensatory evolution



Research in Microbiology 155(5): 360-369



Compensatory mutations, due to their ability to mask the deleterious effects of another mutation, are important for the adaptation and evolution of most organisms. Resistance to antibiotics, antivirals, antifungals, herbicides and insecticides is usually associated with a fitness cost. As a result of compensatory evolution, the initial fitness costs conferred by resistance mutations (or other deleterious mutations) can often be rapidly and efficiently reduced. Such compensatory evolution is potentially of importance for (i) the long-term persistence of drug resistance, (ii) reducing the rate of fitness loss associated with the accumulation of deleterious mutations in small asexual populations, and (iii) the evolution of complexity of cellular processes.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 011729092

Download citation: RISBibTeXText

PMID: 15207868

DOI: 10.1016/j.resmic.2004.01.019


Related references

Compensatory adaptation to the deleterious effect of antibiotic resistance in Salmonella typhimurium. Molecular Microbiology 46(2): 355-366, October, 2002

Compensatory mutations occur within the electrostatic interaction range of deleterious mutations in protein structure. Journal of Molecular Evolution 80(1): 10-12, 2015

Balancing drug resistance and growth rates via compensatory mutations in the Plasmodium falciparum chloroquine resistance transporter. Molecular Microbiology 97(2): 381-395, 2016

The role of compensatory mutations in the emergence of drug resistance. Plos Computational Biology 2(10): E137-E137, 2006

The effects of deleterious mutations on evolution at linked sites. Genetics 190(1): 5-22, 2012

The effects of deleterious mutations on evolution in non-recombining genomes. Trends in Genetics 25(1): 9-12, 2008

Compensatory mutations, antibiotic resistance and the population genetics of adaptive evolution in bacteria. Genetics 154(3): 985-997, 2000

Drug resistance in HIV-1 protease: Flexibility-assisted mechanism of compensatory mutations. Protein Science 11(10): 2393-2402, 2002

Role of compensatory mutations in the emergence of drug resistance (vol 2, pg 1262, 2006). PLoS Computational Biology 3(2): 333, 2007

Dolutegravir-Selected HIV-1 Containing the N155H and R263K Resistance Substitutions Does Not Acquire Additional Compensatory Mutations under Drug Pressure That Lead to Higher-Level Resistance and Increased Replicative Capacity. Journal of Virology 89(20): 10482-8, 2015

Trends in antimicrobial drug use in relation to evolution of antimicrobial resistance in the Intensive Care and Hematology Unit. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 38: 503, 1998

Rescue of deleterious mutations by the compensatory Y30F mutation in ketosteroid isomerase. Molecules and Cells 36(1): 39-46, 2014

Compensatory evolution of pbp mutations restores the fitness cost imposed by β-lactam resistance in Streptococcus pneumoniae. Plos Pathogens 7(2): E1002000-E1002000, 2011

Limited evolution of HIV antiretroviral drug resistance-associated mutations during the performance of drug resistance testing. Journal of Acquired Immune Deficiency Syndromes 32(1): 57-61, 2003

Evolution of transmitted HIV-1 with drug-resistance mutations in the absence of therapy: effects on CD4+ T-cell count and HIV-1 RNA load. Antiviral Therapy 11(2): 173-178, 2006